(Q73644189)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10754210%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Analysis of serum ErbB-2 protein and HLA-DRB1 in Japanese patients with lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10754210%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

C Yoshimura

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10754210%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S Nomura

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10754210%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Yamaoka

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10754210%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

T Ohtani

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10754210%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

T Matsuzakiz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10754210%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

K Yamaguchi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10754210%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S Fukuharal

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10754210%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 April 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10754210%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10754210%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

152

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10754210%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10754210%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

87-95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10754210%20AND%20SRC:MED&resulttype=core&format=json

Toward the primary prevention of cancer

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

Amplification and expression of the c-myc oncogene in human lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

p53 function and dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

Expression and activation of erbB-2 and epidermal growth factor receptor in lung adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

In vitro and in vivo release of soluble erbB-2 protein from human carcinoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

Elevated soluble c-erbB-2 antigen levels in the serum and effusions of a proportion of breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

Prolonged disease-free survival in bronchogenic carcinoma associated with HLA-Aw19 and HLA-B5. A two-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

Histocompatibility locus antigens (HLA) in the epidermoid type of lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

HLA antigens influence resistance to lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

A murine monoclonal antibody that recognizes an extracellular domain of the human c-erbB-2 protooncogene product

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

Microdroplet Assay of Human Serum Cytotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

Effect of warfarin on survival in small cell carcinoma of the lung. Veterans Administration Study No. 75.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

Subcutaneous heparin treatment increases survival in small cell lung cancer. "Petites Cellules" Group

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B study

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

Tumour regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

Cisplatin, gemcitabine and vinorelbine in locally advanced or metastatic non-small-cell lung cancer: a phase I study.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC): comparison of RTOG 83-11 and RTOG 91-06.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

Increased EGF receptors on human squamous carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

Overexpression of c-erbB-2 in epithelial ovarian cancer. Prognostic value and relationship with response to chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

c-erbB-2 oncoprotein assay in ovarian carcinoma and its clinical correlation with prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

c-erbB-2 oncogene expression in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

Activation of c-erbB-2 and prognosis in ovarian carcinoma. Comparison with histologic type, grade, and stage

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

HLA frequency and prognosis in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

Histocompatibility antigens in small cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

Prolonged Survival in Bronchogenic Carcinoma Associated With HL-A Antigens W-19 and HL-A5: A Preliminary Report

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

Naturally processed HLA-DR9/DR53 (DRB1*0901/DRB4*0101)-bound peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

Identification of HLA-DR9 (DRB1*0901)-binding peptide motifs using a phage fUSE5 random peptide library

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

Major histocompatibility complex class II antigens in steroid-sensitive nephrotic syndrome in Chinese children

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

Common west African HLA antigens are associated with protection from severe malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

The study of tumor necrosis factor beta gene polymorphism in lung cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

Decreased frequency of HLA-DRB 1*13 alleles in Frenchwomen with HPV-positive carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

Characterization and functional analysis of the expression of vascular adhesion molecules in human papillomavirus-related disease of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900437-1

7 January 2021

10.1016/S0304-3835(99)00437-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10754210%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference